Real-time enrollment status for this lymphoblastic lymphoma clinical trial
Current Status
Recruiting
Checked: August 29, 2026 at 5:20 PM UTC
| NCT Number | NCT07586618 |
| Recruiting Status | Recruiting |
| Condition | Lymphoblastic Lymphoma |
| Phase | PHASE1 |
| Target Enrollment | 24 participants |
| Active Locations | 5 sites in the US |
| Sponsor | Allterum Therapeutics, Inc |
| Last Updated on CT.gov | July 28, 2026 (Jul 28, 2026) |
As of August 29, 2026: Clinical trial NCT07586618 is currently recruiting participants. This phase1 study for lymphoblastic lymphoma is actively seeking new participants at 5 locations across the United States. The study is sponsored by Allterum Therapeutics, Inc. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07586618 is actively recruiting participants as of August 29, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07586618 was last updated Jul 28, 2026 (July 28, 2026). HelloStudys verifies this status automatically.